(株)中京医薬品の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4558/E03289 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2026/04/17 | 日証協 | 380,846株 | +0.32% | 5,200株 | -89.32% | 1,097,844株 | +0.33% | 8,700株 | +27.94% |
| 2026/04/10 | 日証協 | 379,646株 | -3.56% | 48,700株 | +52.66% | 1,094,244株 | -0.20% | 6,800株 | -98.82% |
| 2026/04/03 | 日証協 | 393,646株 | +5.07% | 31,900株 | +398.44% | 1,096,445株 | +2.04% | 576,030株 | +3100.17% |
| 2026/03/27 | 日証協 | 374,646株 | -2.17% | 6,400株 | 0.00% | 1,074,534株 | -1.11% | 18,000株 | +233.33% |
| 2026/03/19 | 日証協 | 382,946株 | 0.00% | 0株 | 0.00% | 1,086,635株 | +0.37% | 5,400株 | -38.88% |
| 2026/03/13 | 日証協 | 382,946株 | 0.00% | 0株 | -100.00% | 1,082,635株 | +0.20% | 8,835株 | -49.22% |
| 2026/03/06 | 日証協 | 382,946株 | +0.50% | 15,800株 | 0.00% | 1,080,500株 | +1.12% | 17,400株 | +30.83% |
| 2026/02/27 | 日証協 | 381,046株 | -0.05% | 0株 | 0.00% | 1,068,500株 | +0.68% | 13,300株 | +216.67% |
| 2026/02/20 | 日証協 | 381,246株 | -0.13% | 0株 | 0.00% | 1,061,300株 | -0.57% | 4,200株 | +50.00% |
| 2026/02/13 | 日証協 | 381,746株 | 0.00% | 0株 | 0.00% | 1,067,400株 | -0.54% | 2,800株 | -87.50% |
| 2026/02/06 | 日証協 | 381,746株 | -0.10% | 0株 | -100.00% | 1,073,200株 | +0.40% | 22,400株 | -14.83% |
| 2026/01/30 | 日証協 | 382,146株 | -0.10% | 400株 | 0.00% | 1,068,900株 | +0.30% | 26,300株 | -13.20% |
| 2026/01/23 | 日証協 | 382,546株 | -0.68% | 0株 | -100.00% | 1,065,700株 | -0.19% | 30,300株 | +765.47% |
| 2026/01/16 | 日証協 | 385,146株 | -0.08% | 13,400株 | -75.50% | 1,067,700株 | -0.95% | 3,501株 | -71.30% |
| 2026/01/09 | 日証協 | 385,446株 | +1.31% | 54,700株 | 0.00% | 1,077,899株 | +0.49% | 12,200株 | +69.44% |
| 2025/12/30 | 日証協 | 380,446株 | 0.00% | 0株 | -100.00% | 1,072,599株 | -0.77% | 7,200株 | -54.71% |
| 2025/12/26 | 日証協 | 380,446株 | -4.49% | 16,500株 | 0.00% | 1,080,900株 | -1.63% | 15,897株 | +231.19% |
| 2025/12/19 | 日証協 | 398,346株 | -0.05% | 0株 | 0.00% | 1,098,802株 | +0.98% | 4,800株 | -90.98% |
| 2025/12/12 | 日証協 | 398,546株 | -3.18% | 0株 | -100.00% | 1,088,102株 | -0.48% | 53,200株 | +120.75% |
※株式分割は考慮していませんのでご注意ください。
Page Top